Proceedings of the PSK Conference (대한약학회:학술대회논문집)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

DW1350, a Newly Synthetic Anti-osteoporotic Agent: 2. Effect on Ovariectomized Osteoporosis Rat Model, a Histomorphometrical Aspect

  • Lee, Jin-Soo (Central Research Laborotories, Dong-Wha Pharm. Ind. Co., Ltd.) ;
  • Ku, Sae-Kwang (Central Research Laborotories, Dong-Wha Pharm. Ind. Co., Ltd) ;
  • Jung, Da-Hee (Central Research Laborotories, Dong-Wha Pharm. Ind. Co., Ltd) ;
  • Jin, Youn-Goo (Central Research Laborotories, Dong-Wha Pharm. Ind. Co., Ltd) ;
  • Park, Jae-Hoon (Central Research Laborotories, Dong-Wha Pharm. Ind. Co., Ltd) ;
  • Yang, Hee-Bok (Central Research Laborotories, Dong-Wha Pharm. Ind. Co., Ltd) ;
  • Jung, Yong-Ho (Central Research Laborotories, Dong-Wha Pharm. Ind. Co., Ltd) ;
  • Ryu, Jei-Man (Central Research Laborotories, Dong-Wha Pharm. Ind. Co., Ltd.)
  • Published : 2003.04.01
Download PDF
⟨ Previous Next ⟩

Abstract

In the present study, the effect of DW-1350, a newly synthesized anti-osteoporotic agent, was evaluated in ovariectomized Rat. Female SD Rat mice underwent bilateral ovariectomy for prevention study that test article was administered from 2 days after ovariectomy for 6 weeks, for therapeutic study it was conducted from 6 weeks after ovariectomy for three months. (omitted)

Keywords